Torthaí cuardaigh - TOMOMATSU, JUNICHI
- 1 - 19 toradh as 19 á dtaispeáint
-
1
Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution de réir Marshall, Shoko, Nakano, Kenji, Sugiura, Yoshiya, Taira, Shinichiro, Ono, Makiko, Tomomatsu, Junichi, Takahashi, Shunji
Foilsithe / Cruthaithe 2018Téacs -
2
Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis de réir Nakano, Kenji, Motoi, Noriko, Tomomatsu, Junichi, Gokita, Tabu, Ae, Keisuke, Tanizawa, Taisuke, Matsumoto, Seiichi, Takahashi, Shunji
Foilsithe / Cruthaithe 2016Téacs -
3
Richter's Syndrome with Hypercalcemia Induced by Tumor-Associated Production of Parathyroid Hormone-Related Peptide de réir Watanabe, Naoki, Yasuda, Hajime, Morishita, Soji, Aota, Yasuo, Tomomatsu, Junichi, Tanaka, Masaru, Ohsaka, Akimichi, Komatsu, Norio
Foilsithe / Cruthaithe 2017Téacs -
4
Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors de réir Doi, Toshihiko, Fujiwara, Yutaka, Matsubara, Nobuaki, Tomomatsu, Junichi, Iwasa, Satoru, Tanaka, Akari, Endo-Tsukude, Chihiro, Nakagawa, Shintaro, Takahashi, Shunji
Foilsithe / Cruthaithe 2019Téacs -
5
LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer de réir Takahashi, Shunji, Kobayashi, Takayuki, Tomomatsu, Junichi, Ito, Yoshinori, Oda, Hisanobu, Kajitani, Tatsuhiro, Kakizume, Tomoyuki, Tajima, Takeshi, Takeuchi, Hiromi, Maacke, Heiko, Esaki, Taito
Foilsithe / Cruthaithe 2016Téacs -
6
Retrospective Analysis of Trabectedin Therapy for Soft Tissue Sarcoma de réir KAWAGUCHI, KUNIKI, NAKANO, KENJI, URASAKI, TETSUYA, FUKUDA, NAOKI, TAIRA, SHINICHIRO, ONO, MAKIKO, TOMOMATSU, JUNICHI, NISHIZAWA, MASATOSHI, AE, KEISUKE, MATSUMOTO, SEIICHI, TAKAHASHI, SHUNJI
Foilsithe / Cruthaithe 2019Téacs -
7
Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib de réir FUKUDA, NAOKI, WANG, XIAOFEI, OHMOTO, AKIHIRO, URASAKI, TETSUYA, SATO, YASUYOSHI, NAKANO, KENJI, NISHIZAWA, MASATOSHI, YUNOKAWA, MAYU, ONO, MAKIKO, TOMOMATSU, JUNICHI, TAKAHASHI, SHUNJI
Foilsithe / Cruthaithe 2020Téacs -
8
Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer de réir SATO, YASUYOSHI, FUKUDA, NAOKI, FUJIWARA, YU, WANG, XIAOFEI, URASAKI, TETSUYA, OHMOTO, AKIHIRO, NAKANO, KENJI, ONO, MAKIKO, TOMOMATSU, JUNICHI, MITANI, HIROKI, TAKAHASHI, SHUNJI
Foilsithe / Cruthaithe 2021Téacs -
9
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial de réir Sato, Yasuyoshi, Fukuda, Naoki, Wang, Xiaofei, Urasaki, Tetsuya, Ohmoto, Akihiro, Nakano, Kenji, Yunokawa, Mayu, Ono, Makiko, Sato, Yukiko, Mitani, Hiroki, Tomomatsu, Junichi, Takahashi, Shunji
Foilsithe / Cruthaithe 2020Téacs -
10
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study de réir Takahashi, Shunji, Fujiwara, Yutaka, Nakano, Kenji, Shimizu, Toshio, Tomomatsu, Junichi, Koyama, Takafumi, Ogura, Mariko, Tachibana, Masaya, Kakurai, Yasuyuki, Yamashita, Tomonari, Sakajiri, Sakura, Yamamoto, Noboru
Foilsithe / Cruthaithe 2021Téacs -
11
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients de réir Fukuda, Naoki, Yunokawa, Mayu, Fujiwara, Yu, Wang, Xiaofei, Ohmoto, Akihiro, Hayashi, Naomi, Urasaki, Tetsuya, Sato, Yasuyoshi, Nakano, Kenji, Ono, Makiko, Tomomatsu, Junichi, Mitani, Hiroki, Takahashi, Shunji
Foilsithe / Cruthaithe 2020Téacs -
12
Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor‐positive advanced breast cancer de réir Tamura, Kenji, Kodaira, Makoto, Shimizu, Chikako, Yonemori, Kan, Yunokawa, Mayu, Shimomura, Akihiko, Kobayashi, Takayuki, Nakano, Kenji, Tomomatsu, Junichi, Ito, Yoshinori, Tanaka, Jun, Kuriki, Hiroshi, Gu, Zhaodi, Takahashi, Shunji
Foilsithe / Cruthaithe 2018Téacs -
13
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib de réir FUKUDA, NAOKI, TODA, KAZUHISA, FUJIWARA, YU, WANG, XIAOFEI, OHMOTO, AKIHIRO, URASAKI, TETSUYA, HAYASHI, NAOMI, SATO, YASUYOSHI, NAKANO, KENJI, YUNOKAWA, MAYU, ONO, MAKIKO, TOMOMATSU, JUNICHI, MITANI, HIROKI, TAKAHASHI, SHUNJI
Foilsithe / Cruthaithe 2020Téacs -
14
A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors de réir Yamamoto, Noboru, Shimizu, Toshio, Yonemori, Kan, Kitano, Shigehisa, Kondo, Shunsuke, Iwasa, Satoru, Koyama, Takafumi, Sudo, Kazuki, Sato, Jun, Tamura, Kenji, Tomomatsu, Junichi, Ono, Makiko, Fukuda, Naoki, Takahashi, Shunji
Foilsithe / Cruthaithe 2021Téacs -
15
Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy de réir Hayashi, Naomi, Sato, Yasuyoshi, Fujiwara, Yu, Fukuda, Naoki, Wang, Xiaofei, Nakano, Kenji, Urasaki, Testuya, Ohmoto, Akihiro, Ono, Makiko, Tomomatsu, Junichi, Sato, Yukiko, Mitani, Hiroki, Toshiyasu, Takashi, Takahashi, Shunji
Foilsithe / Cruthaithe 2021Téacs -
16
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line de réir Nakano, Kenji, Hayakawa, Keiko, Funauchi, Yuki, Tanizawa, Taisuke, Ae, Keisuke, Matsumoto, Seiichi, Tomomatsu, Junichi, Ono, Makiko, Taira, Shinichiro, Nishizawa, Masatoshi, Wang, Xiaofei, Ohmoto, Akihiro, Sato, Yasuyoshi, Fukuda, Naoki, Urasaki, Tetsuya, Takahashi, Shunji
Foilsithe / Cruthaithe 2021Téacs -
17
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma de réir Ohmoto, Akihiro, Sato, Yukiko, Asaka, Reimi, Fukuda, Naoki, Wang, Xiaofei, Urasaki, Tetsuya, Hayashi, Naomi, Sato, Yasuyoshi, Nakano, Kenji, Yunokawa, Mayu, Ono, Makiko, Tomomatsu, Junichi, Toshiyasu, Takashi, Mitani, Hiroki, Takeuchi, Kengo, Mori, Seiichi, Takahashi, Shunji
Foilsithe / Cruthaithe 2021Téacs -
18
Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue Sarcoma de réir SATO, YASUYOSHI, NAKANO, KENJI, KAWAGUCHI, KUNIKI, FUKUDA, NAOKI, WANG, XIAOFEI, URASAKI, TETSUYA, OHMOTO, AKIHIRO, HAYASHI, NAOMI, YUNOKAWA, MAYU, ONO, MAKIKO, TOMOMATSU, JUNICHI, HAYAKAWA, KEIKO, FUNAUCHI, YUKI, TANIZAWA, TAISUKE, AE, KEISUKE, MATSUMOTO, SEIICHI, TAKAHASHI, SHUNJI
Foilsithe / Cruthaithe 2021Téacs -
19
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma de réir Sato, Yasuyoshi, Nakano, Kenji, Wang, Xiaofei, Fukuda, Naoki, Urasaki, Tetsuya, Ohmoto, Akihiro, Hayashi, Naomi, Yunokawa, Mayu, Ono, Makiko, Tomomatsu, Junichi, Saito, Masanori, Minami, Yusuke, Hayakawa, Keiko, Funauchi, Yuki, Tanizawa, Taisuke, Ae, Keisuke, Matsumoto, Seiichi, Takahashi, Shunji
Foilsithe / Cruthaithe 2021Téacs